Skip to main content

Table 1 Serum marker assessment in swainsonine-treated mice

From: Hematological and histopathological effects of swainsonine in mouse

 

LDH

U/L

ALP

U/L

AST

U/L

ALT

U/L

IBIL

mg/dL

F0-I

783.9 ± 96.2*

269.84 ± 31.58*

184.32 ± 12.5*

65.87 ± 8.57*

0.43 ± 0.03*

F0-II

718.5 ± 95.7*

221.47 ± 32.85*

178.7 ± 10.8*

59.78 ± 9.55*

0.37 ± 0.05*

F0-III

623.8 ± 99.3

193.58 ± 35.87

120.87 ± 11.8

48.47 ± 8.77

0.029 ± 0.02*

F0-IV

587.2 ± 95.8

188.97 ± 27.31

98.11 ± 9.36

41.05 ± 9.58

0.11 ± 0.011

F1-I

547.54 ± 93.25

214.85 ± 7.5

116.58 ± 9.32

47.32 ± 8.50

0.28 ± 0.03*

F1-II

551.87 ± 90.58

218.55 ± 8.1

111.56 ± 9.65

45.36 ± 8.01

0.20 ± 0.01*

F1-III

569.65 ± 85.79

203.51 ± 7.5

105.8 ± 12.21

42.11 ± 7.59

0.18 ± 0.02*

F1-IV

554.88 ± 80.69

198.65 ± 6.8

92.34 ± 8.65

38.25 ± 7.20

0.095 ± 0.02

  1. The values are the mean ± S.D.
  2. *Significantly different from the control group at same generation (P < 0.05).